Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:BASI

Bioanalytical Systems (BASI) Stock Price, News & Analysis

Bioanalytical Systems logo

About Bioanalytical Systems Stock (NASDAQ:BASI)

Key Stats

Today's Range
$3.10
$3.78
50-Day Range
$14.04
$22.50
52-Week Range
$3.05
$21.08
Volume
2.29 million shs
Average Volume
122,925 shs
Market Capitalization
$35.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. BioVaxys has an agreement with Inotiv to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Receive BASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioanalytical Systems and its competitors with MarketBeat's FREE daily newsletter.

BASI Stock News Headlines

When it comes to NVDA… “acceleration cycles” are the key
Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.
10 Analysts Assess NIO: What You Need To Know
What 11 Analyst Ratings Have To Say About Analog Devices
Demystifying Airbnb: Insights From 13 Analyst Reviews
7 Best B2B Database Providers for 2024
See More Headlines

BASI Stock Analysis - Frequently Asked Questions

Bioanalytical Systems, Inc. (NASDAQ:BASI) released its earnings results on Monday, February, 8th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.16. The firm earned $17.89 million during the quarter. Bioanalytical Systems had a negative trailing twelve-month return on equity of 42.74% and a negative net margin of 7.75%.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioanalytical Systems investors own include Meta Platforms (META), Enphase Energy (ENPH), Overstock.com (OSTK), Riot Platforms (RIOT), Twilio (TWLO), Boeing (BA) and NVIDIA (NVDA).

Company Calendar

Last Earnings
2/08/2021
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:BASI
Fax
N/A
Employees
397
Year Founded
N/A

Profitability

Net Income
$-4,680,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$60.47 million
Cash Flow
$0.01 per share
Book Value
$0.69 per share

Miscellaneous

Free Float
N/A
Market Cap
$35.73 million
Optionable
Not Optionable
Beta
1.92
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:BASI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners